Cited by 364Liver Disease Diagnosis and TreatmentEpigenetics and DNA MethylationAlcohol Consumption and Health Effects

Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease

Open access
Pirola, Carlos Jose, Gianotti, Tomas Fernández, Burgueño, Adriana Laura, Rey-Funes, Manuel, Loidl, Cesar Fabian, Mallardi, Pablo, Martino, Julio San, Castaño, Gustavo Osvaldo +1 more·2013·Gut

Abstract

Objective & design: Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that refers to progressive histological changes ranging from simple steatosis (SS) to nonalcoholic steatohepatitis (NASH). We evaluated the status of cytosine methylation (5mC) of liver mitochondrial DNA (mtDNA) in selected regions of the mtDNA genome, such as D-loop control region, and mitochondrially encoded NADH dehydrogenase 6 ( MT-ND6 ) and cytochrome C oxidase I ( MT-CO1 ), to contrast the hypothesis that epigenetic modifications play a role in the phenotypic switching from SS to NASH. Methods: We studied liver biopsies obtained from patients with NAFLD in a case-control design; 45 patients and 18 near-normal liver-histology subjects. Results: MT-ND6 methylation was higher in the liver of NASH than SS patients (p<0.04) and MT-ND6 methylated DNA/unmethylated DNA ratio was significantly associated with NAFLD activity score (p<0.02). Liver MT-ND6 mRNA expression was significantly decreased in NASH patients (0.26±0.30) versus SS (0.74±0.48), p<0.003, and the protein level was also diminished. The status of liver MT-ND6 methylation in NASH group was inversely correlated with the level of regular physical activity ( R =-0.54, p<0.02). Hepatic methylation levels of D-Loop and MT-CO1 were not associated with the disease severity. DNA (cytosine-5) methyltransferase 1 was significantly upregulated in NASH patients (p<0.002). Ultrastructural evaluation showed that NASH is associated with mitochondrial defects and peroxisome proliferation. Conclusion: Hepatic methylation and transcriptional activity of the MT-ND6 are associated with the histological severity of NAFLD. Epigenetic changes of mtDNA are potentially reversible by interventional programs, as physical activity could modulate the methylation status of MT-ND6.

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2012-302962

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Altered mtDNA methylation patterns have been linked to human conditions such as cardiovascular disease, colorectal cancer, non-alcoholic steatohepatitis, obesity-related insulin resistance, and Down syndrome.

    “Human diseases, including cardiovascular diseases110, colorectal cancer111, non-alcoholic steatohepatitis112, obesity-induced insulin resistance113 and Down syndrome114, have also been associated with changes in mtDNA methylation patterns.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pirola, C. J., Gianotti, T. F., Burgueño, A. L., Rey-Funes, M., Loidl, C. F., Mallardi, P., Martino, J. S., Castaño, G. O., & Sookoian, S.
Affiliations
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
  • Institute of Cellular Biology and Neuroscience “Prof. E. De Robertis”, School of Medicine, University of Buenos Aires-National Council of Scientific and Technological Research (CONICET), Ciudad Autónoma de Buenos Aires, Argentina
  • Department of Pathology, Hospital Diego Thompson, San Martin, Buenos Aires, Argentina
  • Liver Unit, Medicine and Surgery Department, Hospital Abel Zubizarreta. Ciudad Autónoma de Buenos Aires, Argentina
Corresponding author
Pirola, Carlos Jose
Venue
Gut
Publisher
BMJ
Published
2012-08-09
Volume
62
Issue
9
Pages
1356-1363
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2106592077
Cited by
364
References
38
Citations by year
2026: 19 · 2025: 26 · 2024: 20 · 2023: 38 · 2022: 26 · 2021: 29 · 2020: 36 · 2019: 28 · 2018: 23 · 2017: 32 · 2016: 31 · 2015: 27 · 2014: 18 · 2013: 10
FWCI
13.13
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, mitochondrial DNA, DNA methylation, MT-ND6, MT-CO1, D-loop, histological severity, physical activity, mitochondrial defects, peroxisome proliferation, steatosis
MeSH terms
DNA (Cytosine-5-)-Methyltransferase 1, Adult, Biopsy, Cytosine, DNA (Cytosine-5-)-Methyltransferases, DNA, Mitochondrial, Fatty Liver, Female, Humans, Liver, Male, Middle Aged, Mitochondria, Liver, NADH Dehydrogenase, Severity of Illness Index, Transcriptional Activation, Case-Control Studies, Disease Progression, DNA Methylation, Epigenesis, Genetic, Gene-Environment Interaction, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review